Clin Pain.
2022 Dec;21(2):74-79. 10.35827/cp.2022.21.2.74.
Digital Therapeutics for the Musculoskeletal Disorders
- Affiliations
-
- 1Department of Rehabilitation Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
- 2Rehabilitation Institute of Neuromuscular Disease, Yonsei University College of Medicine, Seoul, Korea
- 3Department of Integrative Medicine, Yonsei University College of Medicine, Seoul, Korea
- 4Department of Medical Device Engineering and Management, Yonsei University College of Medicine, Seoul, Korea
- KMID: 2537768
- DOI: http://doi.org/10.35827/cp.2022.21.2.74
Abstract
- Digital therapeutics (DTx) is emerging in the field of digital healthcare thanks to the development of ICT (information and communications technology), sensors, and AI (artificial intelligence) technology. A clinical trial-based design and manufacturing process is required for DTx before it can be prescribed in the medical field. The risks, and effectiveness and intended use of DTx must then be approved by regulatory authorities. The digital healthcare apps for musculoskeletal disorders, which had previously concentrated on monitoring and feedback on aerobic exercise, have lately begun to be applied to rehabilitative exercises utilizing AI technologies using convolutional neural networks. The development of DTx focusing on therapeutic rehabilitative exercise is expected in the future.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Current Status and Future Directions of Digital Therapeutics for Insomnia
- Clinical Application of Digital Therapeutics for Insomnia
- A Systematic Review on the Clinical Efficacy of Digital Therapeutics for Sleep Disorders: Subgroup Analysis by Control Groups
- Digital therapeutics and clinical pharmacology
- Introduction to Digital Therapeutics
